Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer

Carcinogenesis

Volumn 34, Issue 4, 2013, Pages 803-811

  Chen, Dong Liang ^a   Wang, De Shen ^a   Wu, Wen Jing ^a   Zeng, Zhao Lei ^a   Luo, Hui Yan ^a   Qiu, Miao Zhen ^a   Ren, Chao ^a   Zhang, Dong Sheng ^a   Wang, Zhi Qiang ^a   Wang, Feng Hua ^a   Li, Yu Hong ^a   Kang, Tie Bang ^a   Xu, Rui Hua ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 137; PAXILLIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; COLONY FORMATION; COLORECTAL CANCER; CORRELATION ANALYSIS; DOWN REGULATION; EMBRYO; GENE OVEREXPRESSION; GENE REPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; MOLECULAR MIMICRY; OVERALL SURVIVAL; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; TUMOR GROWTH;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PAXILLIN; PROGNOSIS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSPLANTATION, HETEROLOGOUS;

EID: 84875914736     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs400     Document Type: Article

References (46)

1. Jemal,A. et al. (2010) Cancer statistics, 2010. CA Cancer J. Clin., 5, 277-300.
2. Wood,L.D. et al. (2007) The genomic landscapes of human breast and colorectal cancers. Science, 5853, 1108-1113.
3. Kudo,Y. et al. (2004) Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous beta-catenin. Clin. Cancer Res., 16, 5455-5463.
4. Kumar,R. et al. (2006) p21-activated kinases in cancer. Nat. Rev. Cancer, 6, 459-471.
5. Schaller,M.D. (2001) Paxillin: a focal adhesion-associated adaptor protein. Oncogene, 44, 6459-6472.
6. Turner,C.E. (2000) Paxillin and focal adhesion signalling. Nat. Cell Biol., 12, E231-E236.
7. Brown,M.C. et al. (2004) Paxillin: adapting to change. Physiol. Rev., 4, 1315-1339.
8. Wu,D.W. et al. (2010) Paxillin predicts survival and relapse in nonsmall cell lung cancer by microRNA-218 targeting. Cancer Res., 24, 10392-10401.
9. Kasai,M. et al. (2003) The Group 3 LIM domain protein paxillin potentiates androgen receptor transactivation in prostate cancer cell lines. Cancer Res., 16, 4927-4935.
10. Li,B.Z. et al. (2008) Increased expression of paxillin is found in human oesophageal squamous cell carcinoma: a tissue microarray study. J. Int. Med. Res., 2, 273-278.
11. Ayaki,M. et al. (2001) Reduced expression of focal adhesion kinase in liver metastases compared with matched primary human colorectal adenocarcinomas. Clin. Cancer Res., 7, 3106-3112.
12. Jun,Q. et al. (2011) Effects of paxillin on HCT-8 human colorectal cancer cells. Hepatogastroenterology, 112, 1951-1955.
13. Pillai,R.S. (2005) MicroRNA function: multiple mechanisms for a tiny RNA? RNA, 12, 1753-1761.
14. Zamore,P.D. et al. (2005) Ribo-gnome: the big world of small RNAs. Science, 5740, 1519-1524.
15. Bartel,D.P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 2, 281-297.
16. Esquela-Kerscher,A. et al. (2006) Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer, 4, 259-269.
17. Calin,G.A. et al. (2006) MicroRNA signatures in human cancers. Nat. Rev. Cancer, 11, 857-866.
18. Bueno,M.J. et al. (2008) Control of cell proliferation pathways by microRNAs. Cell Cycle, 20, 3143-3148.
19. Nicoloso,M.S. et al. (2009) MicroRNAs-the micro steering wheel of tumour metastases. Nat. Rev. Cancer, 4, 293-302.
20. Bemis,L.T. et al. (2008) MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines. Cancer Res., 5, 1362-1368.
21. Langevin,S.M. et al. (2010) MicroRNA-137 promoter methylation in oral rinses from patients with squamous cell carcinoma of the head and neck is associated with gender and body mass index. Carcinogenesis, 5, 864-870.
22. Zhao,Y. et al. (2012) MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells. PLoS ONE, 6, e39102.
23. Balaguer,F. et al. (2010) Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis. Cancer Res., 16, 6609-6618.
24. Teng,K.Y. et al. (2010) DNA polymerase eta protein expression predicts treatment response and survival of metastatic gastric adenocarcinoma patients treated with oxaliplatin-based chemotherapy. J. Transl. Med., 8, 126.
25. Huang,S. et al. (1998) Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis. EMBO J., 15, 4358-4369.
26. John,B. et al. (2004) Human microRNA targets. PLoS Biol., 11, e363.
27. Krek,A. et al. (2005) Combinatorial microRNA target predictions. Nat. Genet., 5, 495-500.
28. Lewis,B.P. et al. (2003) Prediction of mammalian microRNA targets. Cell, 7, 787-798.
29. Sen,A. et al. (2010) Paxillin regulates androgen- and epidermal growth factor-induced MAPK signaling and cell proliferation in prostate cancer cells. J. Biol. Chem., 37, 28787-28795.
30. Mackinnon,A.C. et al. (2011) Paxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic disease. J. Clin. Pathol., 1, 16-24.
31. Li,H.G. et al. (2005) Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma. World J. Gastroenterol., 10, 1445-1451.
32. Shi,J. et al. (2010) Paxillin expression levels are correlated with clinical stage and metastasis in salivary adenoid cystic carcinoma. J. Oral Pathol. Med., 7, 548-551.
33. Volinia,S. et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl Acad. Sci. U.S.A., 7, 2257-2261.
34. Lu,J. et al. (2005) MicroRNA expression profiles classify human cancers. Nature, 7043, 834-838.
35. Zhang,B. et al. (2007) MicroRNAs as oncogenes and tumor suppressors. Dev. Biol., 1, 1-12.
36. Jia,Y. et al. (2013) Epigenetic changes in colorectal cancer. Chin. J. Cancer, 32, 21-30.
37. Kozaki,K. et al. (2008) Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res., 7, 2094-2105.
38. Chen,L. et al. (2012). miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2. Eur. J. Cancer, 48, 3104-11.
39. Wong,T.S. et al. (2008) Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin. Cancer Res., 9, 2588-2592.
40. Liu,M. et al. (2011) miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells. Int. J. Cancer, 6, 1269-1279.
41. Panetti,T.S. (2002) Tyrosine phosphorylation of paxillin, FAK, and p130CAS: effects on cell spreading and migration. Front. Biosci., 7, d143-d150.
42. Schaller,M.D. et al. (2001) Multiple stimuli induce tyrosine phosphorylation of the Crk-binding sites of paxillin. Biochem. J., 360 (Pt 1), 57-66.
43. Chen,H.Y. et al. (2004) Brk activates rac1 and promotes cell migration and invasion by phosphorylating paxillin. Mol. Cell. Biol., 24, 10558-10572.
44. Downey,C. et al. (2008) Pressure activates colon cancer cell adhesion via paxillin phosphorylation, Crk, Cas, and Rac1. Cell. Mol. Life Sci., 9, 1446-1457.
45. Leibovitz,A. et al. (1976) Classification of human colorectal adenocarcinoma cell lines. Cancer Res., 12, 4562-4569.
46. Ding,Q. et al. (2011) APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis. J. Clin. Invest., 11, 4526-4536.